Penetration Testing for Biotech Companies

Biotech companies face attacks on research, clinical trial, and patient data worth billions. Breaches can harm competitive advantage, trigger FDA actions, and risk patient safety.

Cyber threats appear differently in healthcare than they do in fintech, or in SaaS, law, education, or biotech. That’s why Red Sentry delivers penetration testing by industry that matches the regulations and realities of your sector.

RISK

RISK

RISK

Why Biotech Companies Are Targeted

Biotech data are high-value targets for criminals. Here's why attackers focus on Biotech

Research IP Theft

Biotech IP theft costs over $600B annually, driven by nation-state and competitor attacks. A single breach can wipe out years of research advantage and billions in future revenue.

Research IP Theft

Biotech IP theft costs over $600B annually, driven by nation-state and competitor attacks. A single breach can wipe out years of research advantage and billions in future revenue.

Research IP Theft

Biotech IP theft costs over $600B annually, driven by nation-state and competitor attacks. A single breach can wipe out years of research advantage and billions in future revenue.

Clinical Trial Data Risks

Phase III results can move stock prices by billions within minutes. Attackers target trial databases for insider trading and competitive intelligence leverage.

Clinical Trial Data Risks

Phase III results can move stock prices by billions within minutes. Attackers target trial databases for insider trading and competitive intelligence leverage.

Clinical Trial Data Risks

Phase III results can move stock prices by billions within minutes. Attackers target trial databases for insider trading and competitive intelligence leverage.

Vulnerable Lab & Research Systems

Connected lab equipment and automated platforms often run outdated or insecure software. Breaches allow attackers to steal research data or disrupt experiments and production.

Vulnerable Lab & Research Systems

Connected lab equipment and automated platforms often run outdated or insecure software. Breaches allow attackers to steal research data or disrupt experiments and production.

Vulnerable Lab & Research Systems

Connected lab equipment and automated platforms often run outdated or insecure software. Breaches allow attackers to steal research data or disrupt experiments and production.

Collaboration & Regulatory Pressure

Universities, CROs, and manufacturing partners introduce weak security points. Strict rules like 21 CFR Part 11, HIPAA, GDPR, and SEC disclosure timelines increase risk exposure.

Collaboration & Regulatory Pressure

Universities, CROs, and manufacturing partners introduce weak security points. Strict rules like 21 CFR Part 11, HIPAA, GDPR, and SEC disclosure timelines increase risk exposure.

Collaboration & Regulatory Pressure

Universities, CROs, and manufacturing partners introduce weak security points. Strict rules like 21 CFR Part 11, HIPAA, GDPR, and SEC disclosure timelines increase risk exposure.

VULNERABILITIES

VULNERABILITIES

VULNERABILITIES

Common Vulnerabilities

Critical

Weak Access Controls

Insufficient permissions allow unauthorized users into research databases.

Critical

Weak Access Controls

Insufficient permissions allow unauthorized users into research databases.

Critical

Weak Access Controls

Insufficient permissions allow unauthorized users into research databases.

High

Unencrypted Data Transfer

Research data sent to partners without encryption risks interception. Attackers can capture IP during transit.

High

Unencrypted Data Transfer

Research data sent to partners without encryption risks interception. Attackers can capture IP during transit.

High

Unencrypted Data Transfer

Research data sent to partners without encryption risks interception. Attackers can capture IP during transit.

High

Default Credentials on Lab Equipment

Lab instruments still running default usernames and passwords. Easy entry point for attackers to access research systems.

High

Default Credentials on Lab Equipment

Lab instruments still running default usernames and passwords. Easy entry point for attackers to access research systems.

High

Default Credentials on Lab Equipment

Lab instruments still running default usernames and passwords. Easy entry point for attackers to access research systems.

Critical

Missing Audit Logging

Clinical trial systems lack activity logging and monitoring. Breaches go undetected and investigation becomes impossible.

Critical

Missing Audit Logging

Clinical trial systems lack activity logging and monitoring. Breaches go undetected and investigation becomes impossible.

Critical

Missing Audit Logging

Clinical trial systems lack activity logging and monitoring. Breaches go undetected and investigation becomes impossible.

Critical

Weak Authentication

Manufacturing and QA systems rely on weak or single-factor authentication.

Critical

Weak Authentication

Manufacturing and QA systems rely on weak or single-factor authentication.

Critical

Weak Authentication

Manufacturing and QA systems rely on weak or single-factor authentication.

Critical

Insecure File Sharing

Unprotected file sharing exposes confidential research and IP. Unauthorized users can copy or leak critical discoveries.

Critical

Insecure File Sharing

Unprotected file sharing exposes confidential research and IP. Unauthorized users can copy or leak critical discoveries.

Critical

Insecure File Sharing

Unprotected file sharing exposes confidential research and IP. Unauthorized users can copy or leak critical discoveries.

RISK

RISK

RISK

Compliance and Requirements for FinTech

INTEGRATIONS

INTEGRATIONS

INTEGRATIONS

What We Test

What We Test

What We Test

Our penetration tests are tailored to FinTech environments, covering the systems and workflows where breaches cause the most damage.

Our penetration tests are tailored to FinTech environments, covering the systems and workflows where breaches cause the most damage.

Our penetration tests are tailored to FinTech environments, covering the systems and workflows where breaches cause the most damage.

Payment Processing & Transaction Systems

We test for authentication bypass, race conditions enabling double-spending, business logic flaws, insecure authorization, and data access leaks across REST & GraphQL APIs.

APIs & Third-Party Integrations

We identify broken authentication, excessive data exposure, missing rate limiting, token replay risks, and injection vulnerabilities affecting connected services.

Customer Account & Authentication Systems

Testing includes credential-stuffing resilience, weak MFA flows, session hijacking risks, enumeration flaws, and insecure password reset logic.

Mobile Applications

We test for hardcoded keys, insecure local data, SSL certificate weaknesses, sensitive data leakage, and bypassable biometric authentication.

Payment Processing & Transaction Systems

We test for authentication bypass, race conditions enabling double-spending, business logic flaws, insecure authorization, and data access leaks across REST & GraphQL APIs.

APIs & Third-Party Integrations

We identify broken authentication, excessive data exposure, missing rate limiting, token replay risks, and injection vulnerabilities affecting connected services.

Customer Account & Authentication Systems

Testing includes credential-stuffing resilience, weak MFA flows, session hijacking risks, enumeration flaws, and insecure password reset logic.

Mobile Applications

We test for hardcoded keys, insecure local data, SSL certificate weaknesses, sensitive data leakage, and bypassable biometric authentication.

Payment Processing & Transaction Systems

We test for authentication bypass, race conditions enabling double-spending, business logic flaws, insecure authorization, and data access leaks across REST & GraphQL APIs.

Rays

WE OFFER

WE OFFER

WE OFFER

What You Get

Regulatory-Ready Reports

Reports align to 21 CFR 11, HIPAA, ISO 27001, and GxP for FDA inspections and partner audits.

Regulatory-Ready Reports

Reports align to 21 CFR 11, HIPAA, ISO 27001, and GxP for FDA inspections and partner audits.

Regulatory-Ready Reports

Reports align to 21 CFR 11, HIPAA, ISO 27001, and GxP for FDA inspections and partner audits.

Prioritized Remediation

Findings ranked by research impact with clear fixes and technical details for secure, uninterrupted studies.

Prioritized Remediation

Findings ranked by research impact with clear fixes and technical details for secure, uninterrupted studies.

Prioritized Remediation

Findings ranked by research impact with clear fixes and technical details for secure, uninterrupted studies.

Free Retest Included

We retest at no cost to confirm fixes and provide updated documentation for regulatory compliance.

Free Retest Included

We retest at no cost to confirm fixes and provide updated documentation for regulatory compliance.

Free Retest Included

We retest at no cost to confirm fixes and provide updated documentation for regulatory compliance.

Ready to strengthen your security?

If you want clarity on what a pentest would look like for your team, we can walk you through scope, timelines, and what to expect. No pressure commitments.

Ready to strengthen your security?

If you want clarity on what a pentest would look like for your team, we can walk you through scope, timelines, and what to expect. No pressure commitments.

Each Project, Our

If you want clarity on what a pentest would look like for your team, we can walk you through scope, timelines, and what to expect. No pressure commitments.